XPRIZE Healthspan announces 20 finalist teams and awards $1M Milestone 2 prizes

XPRIZE Foundation/XPRIZE Healthspan

XPRIZE named 20 finalist teams from the United States, South Korea, Japan and China to advance to clinical trials. Ten teams received $1 million Milestone 2 awards to support development and testing of their aging interventions, which will be tested in one-year randomized controlled trials with 100-200 participants each, starting in late 2026.